Results 21 to 30 of about 1,719 (152)

Feds focus on naloxone and fentanyl test strips, blame COVID‐19 for OD increases [PDF]

Alcoholism & Drug Abuse Weekly, 2021
Last week, the federal Centers for Disease Control and Prevention (CDC) announced that the predicted overdose death count for the 12‐month period ending April 2021 is more than 100,000. That's one death every five minutes, said Rahul Gupta, M.D., director of the Office of National Drug Control Policy (ONDCP), at a Nov.
europepmc   +3 more sources

‘It wasn’t to get high; it was just to get by’: experiences of patients who use fentanyl during methadone treatment and opportunities for improving care in Vermont and New Hampshire [PDF]

Harm Reduction Journal
Background In March 2020, federal regulations were updated to improve access to methadone for people with opioid use disorder (OUD) during COVID-19, and in February 2024, these COVID-19 flexibilities were further updated and made permanent.
Jesse S. Boggis, Elizabeth C. Saunders, Lisa A. Marsch, Tess Gallant, Kristina Wolff, Cheri Bryer, Ryan Fowler, Daisy J. Goodman   +7 more
doaj   +2 more sources

Urgent Need for Pairing Training and Education With Fentanyl Test Strip Distribution. [PDF]

Drug Alcohol Rev
ABSTRACT Introduction Fentanyl test strips (FTS) are increasingly recommended for non‐heroin drugs to detect potential fentanyl adulteration. The aim of this study was to better understand how people are using FTS. Methods
Reed MK, Esteves Camacho T, Rising KL, Laurano R, Albaciete D, Lankenau SE.   +5 more
europepmc   +2 more sources

Co-development of a community pharmacy training regarding fentanyl and xylazine test strips

Exploratory Research in Clinical and Social Pharmacy
Introduction: Fentanyl and xylazine test strips (FTS, XTS) are simple point-of-care tests that determine the presence of fentanyl or xylazine in a substance before use. Access to FTS and XTS is limited.
Grace Marley, Cheryl Viracola, Ainsley Bryce, Anthony Hudson, Elizabeth Locklear, Bayla Ostrach, Delesha Carpenter   +6 more
doaj   +2 more sources

Using RE-AIM to evaluate the implementation of a social marketing and free product distribution project for fentanyl and xylazine test strips in New York State [PDF]

Harm Reduction Journal
Background Drug test strips can be used to check for the presence of contaminants, such as fentanyl and xylazine in a person’s drug supply. In 2022, New York State began a media campaign and free drug test strip distribution effort throughout the state ...
Hilary M. Kirk, Joshua J. Lynch, Kimberly A. Bernosky, Orian B. Painter, Shelby Arena, Mia Dickinson, Lyudmila Pakhomova, Brian M. Clemency   +7 more
doaj   +2 more sources

Harm reduction engagement and ongoing opioid use among adults receiving methadone or buprenorphine in Philadelphia [PDF]

Harm Reduction Journal
Background Opioid Use Disorder (OUD), a chronic condition with significant health and social consequences, has been intensified by synthetic opioids such as fentanyl.
William Brincheiro, Nolan Chiles, William Jangro, Rachel Haahr, Lara Carson Weinstein   +4 more
doaj   +2 more sources

Characteristics of take-home fentanyl test strip use and support for drug checking services among people who use heroin in Australia: learnings for an increasingly complex drug market [PDF]

Harm Reduction Journal
Background This paper examines: (i) the acceptability of, and behavioural outcomes associated with, take-home fentanyl test strips (FTS), and (ii) support for, and preferences regarding, drug checking services among people who use heroin.
Rachel Sutherland, Maureen Steele, Craig Rodgers, Edmund Silins, Rosie Gilliver, Amy Peacock, Monica Barratt, Nadine Ezard, Krista J. Siefried, Robert Page, Raimondo Bruno, Phillip Read   +11 more
doaj   +2 more sources

Understanding the role of street medicine in harm reduction: a case study of Street Medicine St. Louis [PDF]

Harm Reduction Journal
Background Homelessness results from, and exacerbates, various social determinants of health, including poverty, racism, and inadequate healthcare access, which are further compounded by physical and mental health challenges. The street medicine movement
Ari Gzesh, Jeremiah S. Truel, Danielle R. Adams, Luke Zabotka, Sara Malone, Nathanial S. Nolan   +5 more
doaj   +2 more sources

Perspectives of people in Philadelphia who use fentanyl/heroin adulterated with the animal tranquilizer xylazine; Making a case for xylazine test strips

Drug and Alcohol Dependence Reports, 2022
Background: Xylazine is an animal tranquilizer increasingly detected in those who have died of an opioid overdose in Philadelphia, PA and elsewhere. Despite an increasing presence of xylazine in the local fentanyl/heroin drug market and its association ...
Megan K. Reed, Nicholas S. Imperato, Jeanette M. Bowles, Venise J. Salcedo, Amanda Guth, Kristin L. Rising   +5 more
doaj   +1 more source

Contemporary management of pain in cirrhosis: Toward precision therapy for pain

Hepatology, EarlyView., 2022
Abstract Chronic pain is highly prevalent in patients with cirrhosis and is associated with poor health‐related quality of life and poor functional status. However, there is limited guidance on appropriate pain management in this population, and pharmacologic treatment can be harmful, leading to adverse outcomes, such as gastrointestinal bleeding ...
Alexis Holman, Neehar Parikh, Dan J. Clauw, David A. Williams, Elliot B. Tapper   +4 more
wiley   +1 more source